Cargando…

Minimally invasive pancreatoduodenectomy is associated with lower morbidity compared to open pancreatoduodenectomy: An updated meta-analysis of randomized controlled trials and high-quality nonrandomized studies

BACKGROUND: Minimally invasive pancreatoduodenectomy (MIPD) is being increasingly performed as an alternative to open pancreatoduodenectomy (OPD) in selected patients. Our study aimed to present a meta-analysis of the high-quality studies conducted that compared MIPD to OPD performed for pancreatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Jia-fei, Pan, Yu, Chen, Ke, Zhu, He-pan, Chen, Qi-long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708972/
https://www.ncbi.nlm.nih.gov/pubmed/31393381
http://dx.doi.org/10.1097/MD.0000000000016730
_version_ 1783446100495040512
author Yan, Jia-fei
Pan, Yu
Chen, Ke
Zhu, He-pan
Chen, Qi-long
author_facet Yan, Jia-fei
Pan, Yu
Chen, Ke
Zhu, He-pan
Chen, Qi-long
author_sort Yan, Jia-fei
collection PubMed
description BACKGROUND: Minimally invasive pancreatoduodenectomy (MIPD) is being increasingly performed as an alternative to open pancreatoduodenectomy (OPD) in selected patients. Our study aimed to present a meta-analysis of the high-quality studies conducted that compared MIPD to OPD performed for pancreatic head and periampullary diseases. METHODS: A systematic review of the available literature was performed to identify those studies conducted that compared MIPD to OPD. Here, all randomized controlled trials identified were included, while the selection of high-quality, nonrandomized comparative studies were based on a validated tool (i.e., Methodological Index for Nonrandomized Studies). Intraoperative outcomes, postoperative recovery, oncologic clearance, and postoperative complications were also evaluated. RESULTS: Sixteen studies matched the selection criteria, including a total of 3168 patients (32.1% MIPD, 67.9% OPD). The pooled data showed that MIPD was associated with a longer operative time (weighted mean difference [WMD] = 80.89 minutes, 95% confidence interval [CI]: 39.74–122.05, P < .01), less blood loss (WMD = −227.62 mL, 95% CI: −305.48 to −149.75, P < .01), shorter hospital stay (WMD = −4.68 days, 95% CI: −5.52 to −3.84, P < .01), and an increase in retrieved lymph nodes (WMD = 1.85, 95% CI: 1.33–2.37, P < .01). Furthermore, the overall morbidity was significantly lower in the MIPD group (OR = 0.67, 95% CI: 0.54–0.82, P < .01), as were total postoperative pancreatic fistula (POPF) (OR = 0.79, 95% CI: 0.63–0.99, P = .04), delayed gastric emptying (DGE) (OR = 0.71, 95% CI: 0.52–0.96, P = .02), and wound infection (OR = 0.56, 95% CI: 0.39–0.79, P < .01). However, there were no statistically significant differences observed in major complications, clinically significant POPFs, reoperation rate, and mortality. CONCLUSION: Our study suggests that MIPD is a safe alternative to OPD, as it is associated with less blood loss and better postoperative recovery in terms of the overall postoperative complications as well as POPF, DGE, and wound infection. Methodologic high-quality comparative studies are required for further evaluation.
format Online
Article
Text
id pubmed-6708972
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-67089722019-10-01 Minimally invasive pancreatoduodenectomy is associated with lower morbidity compared to open pancreatoduodenectomy: An updated meta-analysis of randomized controlled trials and high-quality nonrandomized studies Yan, Jia-fei Pan, Yu Chen, Ke Zhu, He-pan Chen, Qi-long Medicine (Baltimore) Research Article BACKGROUND: Minimally invasive pancreatoduodenectomy (MIPD) is being increasingly performed as an alternative to open pancreatoduodenectomy (OPD) in selected patients. Our study aimed to present a meta-analysis of the high-quality studies conducted that compared MIPD to OPD performed for pancreatic head and periampullary diseases. METHODS: A systematic review of the available literature was performed to identify those studies conducted that compared MIPD to OPD. Here, all randomized controlled trials identified were included, while the selection of high-quality, nonrandomized comparative studies were based on a validated tool (i.e., Methodological Index for Nonrandomized Studies). Intraoperative outcomes, postoperative recovery, oncologic clearance, and postoperative complications were also evaluated. RESULTS: Sixteen studies matched the selection criteria, including a total of 3168 patients (32.1% MIPD, 67.9% OPD). The pooled data showed that MIPD was associated with a longer operative time (weighted mean difference [WMD] = 80.89 minutes, 95% confidence interval [CI]: 39.74–122.05, P < .01), less blood loss (WMD = −227.62 mL, 95% CI: −305.48 to −149.75, P < .01), shorter hospital stay (WMD = −4.68 days, 95% CI: −5.52 to −3.84, P < .01), and an increase in retrieved lymph nodes (WMD = 1.85, 95% CI: 1.33–2.37, P < .01). Furthermore, the overall morbidity was significantly lower in the MIPD group (OR = 0.67, 95% CI: 0.54–0.82, P < .01), as were total postoperative pancreatic fistula (POPF) (OR = 0.79, 95% CI: 0.63–0.99, P = .04), delayed gastric emptying (DGE) (OR = 0.71, 95% CI: 0.52–0.96, P = .02), and wound infection (OR = 0.56, 95% CI: 0.39–0.79, P < .01). However, there were no statistically significant differences observed in major complications, clinically significant POPFs, reoperation rate, and mortality. CONCLUSION: Our study suggests that MIPD is a safe alternative to OPD, as it is associated with less blood loss and better postoperative recovery in terms of the overall postoperative complications as well as POPF, DGE, and wound infection. Methodologic high-quality comparative studies are required for further evaluation. Wolters Kluwer Health 2019-08-09 /pmc/articles/PMC6708972/ /pubmed/31393381 http://dx.doi.org/10.1097/MD.0000000000016730 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle Research Article
Yan, Jia-fei
Pan, Yu
Chen, Ke
Zhu, He-pan
Chen, Qi-long
Minimally invasive pancreatoduodenectomy is associated with lower morbidity compared to open pancreatoduodenectomy: An updated meta-analysis of randomized controlled trials and high-quality nonrandomized studies
title Minimally invasive pancreatoduodenectomy is associated with lower morbidity compared to open pancreatoduodenectomy: An updated meta-analysis of randomized controlled trials and high-quality nonrandomized studies
title_full Minimally invasive pancreatoduodenectomy is associated with lower morbidity compared to open pancreatoduodenectomy: An updated meta-analysis of randomized controlled trials and high-quality nonrandomized studies
title_fullStr Minimally invasive pancreatoduodenectomy is associated with lower morbidity compared to open pancreatoduodenectomy: An updated meta-analysis of randomized controlled trials and high-quality nonrandomized studies
title_full_unstemmed Minimally invasive pancreatoduodenectomy is associated with lower morbidity compared to open pancreatoduodenectomy: An updated meta-analysis of randomized controlled trials and high-quality nonrandomized studies
title_short Minimally invasive pancreatoduodenectomy is associated with lower morbidity compared to open pancreatoduodenectomy: An updated meta-analysis of randomized controlled trials and high-quality nonrandomized studies
title_sort minimally invasive pancreatoduodenectomy is associated with lower morbidity compared to open pancreatoduodenectomy: an updated meta-analysis of randomized controlled trials and high-quality nonrandomized studies
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708972/
https://www.ncbi.nlm.nih.gov/pubmed/31393381
http://dx.doi.org/10.1097/MD.0000000000016730
work_keys_str_mv AT yanjiafei minimallyinvasivepancreatoduodenectomyisassociatedwithlowermorbiditycomparedtoopenpancreatoduodenectomyanupdatedmetaanalysisofrandomizedcontrolledtrialsandhighqualitynonrandomizedstudies
AT panyu minimallyinvasivepancreatoduodenectomyisassociatedwithlowermorbiditycomparedtoopenpancreatoduodenectomyanupdatedmetaanalysisofrandomizedcontrolledtrialsandhighqualitynonrandomizedstudies
AT chenke minimallyinvasivepancreatoduodenectomyisassociatedwithlowermorbiditycomparedtoopenpancreatoduodenectomyanupdatedmetaanalysisofrandomizedcontrolledtrialsandhighqualitynonrandomizedstudies
AT zhuhepan minimallyinvasivepancreatoduodenectomyisassociatedwithlowermorbiditycomparedtoopenpancreatoduodenectomyanupdatedmetaanalysisofrandomizedcontrolledtrialsandhighqualitynonrandomizedstudies
AT chenqilong minimallyinvasivepancreatoduodenectomyisassociatedwithlowermorbiditycomparedtoopenpancreatoduodenectomyanupdatedmetaanalysisofrandomizedcontrolledtrialsandhighqualitynonrandomizedstudies